Britain's Royal College of Pathologists, as well as other scientific associations, is calling for better regulation of at-home testing kits for disease, including genetic disease. They will be telling members of Parliament that companies offering these tests should deposit the data on the product's efficacy in a database so that their claims can be tested and that an official body should be set up to monitor these products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.